Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. - Wikidata - wikimedia - TriplyDB

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

http://www.wikidata.org/entity/Q34216753

about

Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophy Drugs in development: bisphosphonates and metalloproteinase inhibitors Direct effects of bisphosphonates on breast cancer cells.Management of Root Resorption Using Chemical Agents: A Review Molecular Aspects of Bone Resorption in β-Thalassemia Major Periprosthetic bone loss: diagnostic and therapeutic approaches Bisphosphonates induce apoptosis in human breast cancer cell lines Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel Immunocytochemical study of amelogenin deposition during the early odontogenesis of molars in alendronate-treated newborn rats Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy.Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality The pharmacology of bisphosphonates and new insights into their mechanisms of action.Bisphosphonates: from grandparents to grandchildren.Direct antitumour activity of zoledronic acid: preclinical and clinical data.The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes.Osteonecrosis of the jaw in a patient on Denosumab.Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma.Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.Effect of bisphosphonates on the progression of degenerative aortic stenosis.The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment Pathophysiology of Bone Remodelling and Current Therapeutic Approaches.Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study.Vγ9Vδ2 T lymphocytes activation in osteoporotic patients treated with bisphosphonates.Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses.Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate.Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.Are bisphosphonates effective in the treatment of osteoarthritis pain? A meta-analysis and systematic review.Influence of alendronate and endplate degeneration to single level posterior lumbar spinal interbody fusion.Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migration.Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo Intracellular membrane trafficking in bone resorbing osteoclasts.

P2860

Q24198280-0EEA07DF-BDAE-4920-8A45-B5DD65E2E0E7 Q24795847-AC49670D-1CA7-4C5C-A252-6EA023EF514E Q24802079-DDB764C7-69A7-450D-8DA4-FD3836E390F1 Q26769589-834DFD83-13DC-49B3-9FC3-574710F44E69 Q26801066-93C1E3EB-A7B6-4DBA-8CAE-669EFE236E28 Q27024847-5353B6A6-E460-4DBE-98EB-301C1230879B Q28344185-2268363E-4DFB-4E0D-AEA8-5F1BB6C0F788 Q28361973-8519560F-C4F4-41D8-83F3-5FB011D2F9F2 Q28362972-A5C85446-7D38-46B5-87CB-2B961788CA2F Q28582189-63578793-8625-4143-9B0C-FA58649D7281 Q31048527-9AC75D73-07EB-456A-95E8-CBC1B6EED1E9 Q33221328-00487410-606A-4DE6-AACF-0BDA4696E15E Q33269187-74011394-8900-4085-BE91-9EDEC8A3B138 Q33591699-9DDC96D1-2530-4869-BF4F-A50344F6972D Q33746152-7CA89FD8-14BA-4C45-B9CD-2BC5F89D7FCE Q33807859-F1658DF5-A2BB-4D91-91F0-919D51C2BCAE Q33850938-4DA748DA-B158-40BF-B60D-F48AF1053AE5 Q33867998-1AB2D366-4F72-48C2-96DB-88D847A0DF7E Q33891868-DD67A3A7-D652-412E-9FCF-3273D32F41CE Q33898760-D1E3A3A7-AF15-4E23-83C3-645A629C921F Q33970512-EC2CD175-48DF-49DE-A52A-065F26C4FBAE Q34009569-BF71BA5A-3FB7-476B-96E1-09C0C53E0AEB Q34129152-2769E0D0-215A-480B-A220-EA2893146B9A Q34153137-1449BE76-25E3-43CF-94B6-487E1C98EA81 Q34182079-B5FA8997-E0ED-40EF-84D9-D18D25644B70 Q34209614-570DAAFA-2C2F-474C-AFDE-092C8E0B6512 Q34216887-1F62F6A8-1002-48C3-B96A-55E9EF9A4F38 Q34230320-E73089EF-E81B-4D77-B159-85482C740ECF Q34480630-548CE667-0E6A-4A54-9FB3-92FD53BD7A83 Q34574959-DC81FCF1-ED33-4DD5-A7CD-D6BF62D09307 Q34765492-A79E5102-F7D4-4E28-B885-DCBAB7F84578 Q34765502-1890EE1E-D92F-4BA3-BC10-57B1942D906C Q34793691-4D5EAF84-5B5B-4CE9-9E7E-E90F1A3F69B6 Q34890347-38031325-0F7E-469D-B7E7-7B0DBC0C3D91 Q34984018-2F19BC91-9076-465F-83E6-3518F76D0D49 Q35001021-17DFFE73-C3AB-42B0-8841-A6F89CBBC0C2 Q35026446-A001415E-5E51-461C-99D3-6E8E23A1BCE6 Q35115510-50AE90F0-A548-4919-891D-6EEE46324193 Q35156294-56FCF714-B8BC-47B9-A3E1-36A0FCE96796 Q35184299-6E435184-415C-4128-8EFF-C36CAACF1E6C

P2860

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

http://www.wikidata.org/entity/Q34216753

description

1991 nî lūn-bûn

@nan

1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

name

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@ast

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@en

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@nl

type

label

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@ast

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@en

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@nl

prefLabel

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@ast

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@en

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@nl

P1433

Q34216753-09A07C93-CF2C-4837-B9AB-918ECB590E6B

P1476

Q34216753-5316DE97-F3D6-4781-B82C-F4AE6261E568

P2093

Q34216753-2541939A-6210-4B36-A702-393FE6076B72

Q34216753-40FF1413-5CD7-4D1C-B73D-BEF1FAABB4FF

Q34216753-5EE98FC7-E218-49A9-94A5-3CB53FE97B34

Q34216753-6589CC1E-E9C9-4242-BE4C-C2D0A951F5C2

Q34216753-80EB001B-2C4C-4750-B9C8-F85691D38B14

Q34216753-8E5E41CB-17CE-4426-9197-B28AE8A6DEC7

Q34216753-C28E83BA-FA7C-4835-93E6-9D8B00BB5F47

Q34216753-FFEDA337-945A-4C31-B62B-3A01D9CAF878

P2860

Q34216753-08D472A4-CFC6-46B7-BEE7-E12BA5731D8C

Q34216753-0FF9276D-696C-47F6-8D50-4CB982ED083F

Q34216753-1C388CD6-BD5C-4DB0-8AB9-A86E383E7B57

Q34216753-1DFB14EB-AD1C-495B-9765-C1A7FE0FDF87

Q34216753-28272BBC-E783-4399-AFF7-D669F58B08CF

Q34216753-292DE483-678A-4927-96B6-649A9E64840C

Q34216753-2E835D6A-D34A-4D07-80B8-E2C4BFE5F86E

Q34216753-32E72300-A65C-4AAE-A6C5-3C67584BDD7B

Q34216753-36710EC6-EADF-4B75-B105-106AB6703216

Q34216753-383DB9F4-BAC8-4CBA-AA80-A903F6A23C99

P304

Q34216753-D5A709BE-5DE4-46B9-A40F-2B3855896A7E

P31

Q34216753-4829D86D-84B8-42FC-83BD-8FF3A73B24FB

P356

Q34216753-2CF1FE3D-AC9E-446B-81BE-5E5D6A01593F

P407

Q34216753-BB3EC6D7-41D3-4F78-B5EC-967FD4BB73CB

P433

Q34216753-118247B3-ECBF-4F41-966C-10C6AB1D6A1D

P478

Q34216753-8E2B00FD-11E2-46C5-9310-05E22497A1E8

P577

Q34216753-2EA8B7FC-2953-42BC-B500-C2CF4DBDB002

P698

Q34216753-025F7C4E-47C1-4BDF-A153-F36A53CAB2DE

P932

Q34216753-CEC8AF44-EED6-4944-85F2-418DB6842FB9

P356

P1433

Journal of Clinical Investigation

P1476

Bisphosphonate action. Alendro ...... on osteoclast ultrastructure.

@en

P2093

Akins R

http://www.w3.org/2001/XMLSchema#string

Endo N

http://www.w3.org/2001/XMLSchema#string

Golub E

http://www.w3.org/2001/XMLSchema#string

Grasser W

http://www.w3.org/2001/XMLSchema#string

Rodan GA

http://www.w3.org/2001/XMLSchema#string

Sato M

http://www.w3.org/2001/XMLSchema#string

Simmons H

http://www.w3.org/2001/XMLSchema#string

Thompson DD

http://www.w3.org/2001/XMLSchema#string

P2860

Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization

The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.

Direct action of the parathyroid hormone-like human hypercalcemic factor on bone.

Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).

Echistatin is a potent inhibitor of bone resorption in culture

Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.

Comparison of different dose regimes of aminohydroxypropylidene-1,1-bisphosphonate (APD) in hypercalcaemia of malignancy.

Osteoclastic bone resorption by a polarized vacuolar proton pump.

Treatment of malignant hypercalcaemia with clodronate.

Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border.

P304

2095-2105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI115539

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

1991-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1661297

http://www.w3.org/2001/XMLSchema#string

P932

295810

http://www.w3.org/2001/XMLSchema#string